Prescription of antibiotic agents in Swedish intensive care units is empiric and precise

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 1, 2007, Pages 63-69

  Erlandsson, Marcus ^a   Burman, Lars G ^b   Cars, Otto ^b   Gill, Hans ^c   Nilsson, Lennart E ^a   Walther, Sten M ^c   Hanberger, Håkan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c Medical Informatics ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; AMPICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CEFADROXIL; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; BLOOD CULTURE; CATHETER INFECTION; DRUG CHOICE; DRUG INDICATION; DRUG USE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NONHUMAN; PRESCRIPTION; PROSPECTIVE STUDY; SEPSIS; SURGICAL INFECTION; SWEDEN; THROMBOCYTE COUNT; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; PHYSICIAN'S PRACTICE PATTERNS; SWEDEN;

EID: 33847150926     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600740504     Document Type: Article

References (41)

1. Gruson, D., Hilbert, G., Vargas, F., Valentino, R., Bebear, C. and Allery, A. (2000) Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med, 162, pp. 837-843.
2. Hanberger, H., Diekema, D., Fluit, A., Jones, R., Struelens, M. and Spencer, R. (2001) Surveillance of antibiotic resistance in European ICUs. J Hosp Infect, 48, pp. 161-176.
3. Erlandsson, CM, Hanberger, H., Eliasson, I., Hoffmann, M., Isaksson, B. and Lindgren, S. (1999) Surveillance of antibiotic resistance in ICUs in south-eastern Sweden. ICU Study Group of the South East of Sweden. Acta Anaesthesiol Scand, 43, pp. 815-820.
4. Kiivet, RA, Dahl, ML, Llerena, A., Maimets, M., Wettermark, B. and Berecz, R. (1998) Antibiotic use in 3 European university hospitals. Scand J Infect Dis, 30, pp. 277-280.
5. Lemmen, SW, Hafner, H., Kotterik, S., Lutticken, R. and Topper, R. (2000) Influence of an infectious disease service on antibiotic prescription behaviour and selection of multi-resistant pathogens. Infection, 28, pp. 384-387.
6. Naaber, P., Koljalg, S. and Maimets, M. (2000) Antibiotic usage and resistance trends in Estonian university hospitals. Int J Antimicrob Agents, 16, pp. 309-315.
7. Petersen, IS, Hesselbjerg, L., Jorgensen, L., Renstrup, J., Barnung, S. and Schierbeck, J. (1999) High antibiotic consumption in Danish intensive care units?. APMIS, 107, pp. 989-996.
8. Vlahovic-Palcevski, V., Morovic, M. and Palcevski, G. (2000) Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol, 56, pp. 97-101.
9. Walther, SM, Erlandsson, M., Burman, LG, Cars, O., Gill, H. and Hoffman, M. (2002) Antibiotic prescription practices, consumption and bacterial resistance in a cross-section of Swedish intensive care units. Acta Anaesthesiol Scand, 46, pp. 1075-1081.
10. Nguyen, HB, Rivers, EP, Havstad, S., Knoblich, B., Ressler, JA and Muzzin, AM (2000) Critical care in the emergency department: A physiological assessment and outcome evaluation. Acad Emerg Med, 7, pp. 1354-1361.
11. Bonten, MJ, Kollef, MH and Hall, JB. (2004) Risk factors for ventilator-associated pneumonia: From epidemiology to patient management. Clin Infect Dis, 38, pp. 1141-1149.
12. Hill, PC, Birch, M., Chambers, S., Drinkovic, D., Ellis-Pegler, RB and Everts, R. (2001) Prospective study of 424 cases of Staphylococcus aureus bacteraemia: Determination of factors affecting incidence and mortality. Intern Med J, 31, pp. 97-103.
13. Bonten, MJ and Mascini, EM. (2003) The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med, 29, pp. 1-2.
14. Struelens, MJ, Byl, B. and Vincent, JL. (1999) Antibiotic policy: A tool for controlling resistance of hospital pathogens. Clin Microbiol Infect, 5, p. S19.
15. Gustafsson, I., Sjolund, M., Torell, E., Johannesson, M., Engstrand, L. and Cars, O. (2003) Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother, 52, pp. 645-650.
16. Grundmann, H., Hori, S., Winter, B., Tami, A. and Austin, DJ. (2002) Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: Fitting a model to the data. J Infect Dis, 185, pp. 481-488.
17. Maxwell, M., Heaney, D., Howie, JG and Noble, S. (1993) General practice fundholding: Observations on prescribing patterns and costs using the defined daily dose method. Br Med J, 307, pp. 1190-1194.
18. Bergman, U., Christenson, I., Jansson, B. and Wiholm, BE. (1980) Auditing hospital drug utilization by means of defined daily doses per bed-d. A methodological study. Eur J Clin Pharmacol, 17, pp. 183-187.
19. Hanberger, H., Erlandsson, M., Burman, LG, Cars, O., Gill, H. and Lindgren, S. (2004) High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance programme using TA90 as a novel index of susceptibility. Scand J Infect Dis, 36, pp. 24-30.
20. Olsson-Liljequist, B., Larsson, P., Walder, M. and Miorner, H. (1997) Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl, 105, pp. 13-23.
21. Bergmans, DC, Bonten, MJ, Gaillard, CA, van Tiel, FH, van der Geest, S. and de Leeuw, PW (1997) Indications for antibiotic use in ICU patients: a 1-y prospective surveillance. J Antimicrob Chemother, 39, pp. 527-535.
22. Capella, D. (1993) Descriptive tools and analysis. WHO Reg Publ Eur Ser, 45, pp. 55-78.
23. Fridkin, SK, Steward, CD, Edwards, JR, Pryor, ER, McGowan Jr, JE and Archibald, LK (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis, 29, pp. 245-252.
24. Fischer, JE, Ramser, M. and Fanconi, S. (2000) Use of antibiotics in paediatric intensive care and potential savings. Intensive Care Med, 26, pp. 959-966.
25. Kollef, MH and Ward, S. (1998) The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest, 113, pp. 412-420.
26. Kollef, MH. (1999) Improving outcomes in the ICU setting: Are we effectively using all of the information that is potentially available to us?. Chest, 115, pp. 1490-1492.
27. Zaidi, M., Sifuentes-Osornio, J., Rolon, AL, Vazquez, G., Rosado, R. and Sanchez, M. (2002) Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch Med Res, 33, pp. 290-294.
28. Schurink, CA, Hoitsma, M., Rozenberg-Arska, M., Joore, JC, Hoepelman, IM and Bonten, MJ. (2004) Do cultures contribute to optimization of antibiotic therapy in the intensive care unit?. Int J Antimicrob Agents, 23, pp. 325-331.
29. Diaz, E. and Rello, J. (2002) Top ten list in antibiotic policy in the ICU. Chest, 122, pp. 712-714.
30. Evans, RS, Pestotnik, SL, Classen, DC, Clemmer, TP, Weaver, LK and Orme Jr, JF (1998) A computer-assisted management programme for antibiotics and other anti-infective agents. N Engl J Med, 338, pp. 232-238.
31. Pestotnik, SL, Classen, DC, Evans, RS and Burke, JP. (1996) Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med, 124, pp. 884-890.
32. Dupont, H., Mentec, H., Sollet, JP and Bleichner, G. (2001) Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med, 27, pp. 355-362.
33. Heyland, DK, Cook, DJ, Griffith, L., Keenan, SP and Brun-Buisson, C. (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med, 159, pp. 1249-1256.
34. Alvarez-Lerma, F. (1996) Modification of empirical antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med, 22, pp. 387-394.
35. Rello, J., Gallego, M., Mariscal, D., Sonora, R. and Valles, J. (1997) The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med, 156, pp. 196-200.
36. Luna, CM, Vujacich, P., Niederman, MS, Vay, C., Gherardi, C. and Matera, J. (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 111, pp. 676-685.
37. Skoog, GCO, Skärlund, K., Elowson, S., Hanberger, H., Odenholt, I. and Prag, M. (2004) Point prevalence study of antibiotic use in Swedish hospitals. ECCMID, Prague
38. Bailey, TC and McMullin, S. Troy (2001) Using information systems technology to improve antibiotic prescribing. Crit Care Med, 29, pp. 87-91.
39. Vincent, JL, Bihari, DJ, Suter, PM, Bruining, HA, White, J. and Nicolas-Chanoin, MH (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA, 274, pp. 639-644.
40. Saeedi, B., Hallgren, A., Isaksson, B., Jonasson, J., Nilsson, LE and Hanberger, H. (1994) Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in south-east Sweden-2001. Scand J Infect Dis; 36, 2004, pp. 405-409.
41. Hallgren, A., Saeedi, B., Nilsson, M., Monstein, HJ, Isaksson, B. and Hanberger, H. (2003) Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units. J Antimicrob Chemother, 52, pp. 162-167.